Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Mallinckrodt
Accenture
Baxter
Cipla
Boehringer Ingelheim

Generated: July 23, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,427,402

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which drugs does patent 9,427,402 protect, and when does it expire?

Patent 9,427,402 protects MULPLETA and is included in one NDA.

This patent has fourteen patent family members in nine countries.

Summary for Patent: 9,427,402
Title:Preparation for improving solubility of poorly soluble drug
Abstract: The present invention relates to solubility improving preparation for enhancing the oral absorption of a poorly soluble drug, which is comprising (A) and (B); (A) a granulated substance which comprises (i) a poorly soluble drug having an acidic group in the molecule, (ii) an alkaline agent, (iii) a surfactant, and this granulated substance dose not substantially contain a disintegrator, (B) a disintegrator existing only in the external of the granulated substance.
Inventor(s): Sakuma; Satoshi (Amagasaki, JP), Ueda; Hiroshi (Toyonaka, JP), Mashimo; Akira (Amagasaki, JP), Murazato; Hiroshi (Osaka, JP)
Assignee: Shionogi & Co. Ltd. (Osaka, JP)
Application Number:13/825,552
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 9,427,402
Patent Claim Types:
see list of patent claims
Use; Compound; Process; Dosage form;

Drugs Protected by US Patent 9,427,402

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Shionogi Inc MULPLETA lusutrombopag TABLET;ORAL 210923-001 Jul 31, 2018 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Foreign Priority and PCT Information for Patent: 9,427,402

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2010-221000Sep 30, 2010
PCT Information
PCT FiledSeptember 29, 2011PCT Application Number:PCT/JP2011/072355
PCT Publication Date:April 05, 2012PCT Publication Number: WO2012/043709

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Argus Health
Cantor Fitzgerald
Express Scripts
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.